D

Delfi Diagnostics

195 employees

Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Medical

Date founded

2019

Funding rounds raised

Total raised

$225M

from 23 investors over 23 rounds

D

Delfi Diagnostics raised $225M on July 18, 2022

Investors: PTX Capital, OrbiMed Advisors, -, T. Rowe Price, Osage University Partners (OUP), Samsara BioCapital, Point72 Asset Management, Windham Venture Partners and Point Field Partners

D

Delfi Diagnostics raised $100M on January 12, 2021

Investors: Foresite Capital, T. Rowe Price, Osage University Partners (OUP), Illumina Ventures, OrbiMed Advisors, Windham Venture Partners, Menlo Ventures, Northpond Ventures and Samsara BioCapital

D

Delfi Diagnostics raised $5.5M on August 12, 2019

Investors: Menlo Ventures, Samsara BioCapital, Illumina Ventures, AV8 Ventures and Windham Venture Partners

FAQ